News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
770,181 Results
Type
Article (51592)
Company Profile (313)
Press Release (718269)
Multimedia
Podcasts (145)
Webinars (23)
Section
Business (218312)
Career Advice (3130)
Deals (36980)
Drug Delivery (128)
Drug Development (84776)
Employer Resources (188)
FDA (17285)
Job Trends (16039)
News (367954)
Policy (35323)
Tag
Academia (2841)
Academic (1)
Accelerated approval (21)
Adcomms (28)
Allergies (130)
Alliances (53702)
ALS (155)
Alzheimer's disease (1677)
Antibody-drug conjugate (ADC) (269)
Approvals (17414)
Artificial intelligence (507)
Autoimmune disease (111)
Automation (33)
Bankruptcy (370)
Best Places to Work (12273)
BIOSECURE Act (22)
Biosimilars (176)
Biotechnology (205)
Bladder cancer (143)
Brain cancer (57)
Breast cancer (554)
Cancer (4365)
Cardiovascular disease (375)
Career advice (2656)
Career pathing (39)
CAR-T (253)
CDC (50)
Cell therapy (702)
Cervical cancer (33)
Clinical research (71314)
Collaboration (1506)
Company closure (5)
Compensation (1018)
Complete response letters (49)
COVID-19 (2853)
CRISPR (88)
C-suite (697)
Cystic fibrosis (142)
Data (5439)
Decentralized trials (2)
Denatured (51)
Depression (116)
Diabetes (461)
Diagnostics (6964)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (232)
Drug pricing (189)
Drug shortages (32)
Duchenne muscular dystrophy (209)
Earnings (94205)
Editorial (58)
Employer branding (23)
Employer resources (166)
Events (125056)
Executive appointments (995)
FDA (20005)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1360)
Gene editing (192)
Generative AI (49)
Gene therapy (571)
GLP-1 (982)
Government (5069)
Grass and pollen (8)
Guidances (375)
Healthcare (20368)
HIV (49)
Huntington's disease (41)
IgA nephropathy (78)
Immunology and inflammation (242)
Immuno-oncology (26)
Indications (69)
Infectious disease (3104)
Inflammatory bowel disease (186)
Inflation Reduction Act (15)
Influenza (105)
Intellectual property (208)
Interviews (552)
IPO (17037)
IRA (56)
Job creations (4135)
Job search strategy (2216)
Kidney cancer (15)
Labor market (81)
Layoffs (592)
Leadership (38)
Legal (8753)
Liver cancer (91)
Longevity (13)
Lung cancer (609)
Lymphoma (321)
Machine learning (36)
Management (65)
Manufacturing (677)
MASH (159)
Medical device (14418)
Medtech (14455)
Mergers & acquisitions (20908)
Metabolic disorders (1171)
Multiple sclerosis (145)
NASH (19)
Neurodegenerative disease (285)
Neuropsychiatric disorders (71)
Neuroscience (2779)
NextGen: Class of 2025 (7174)
Non-profit (4993)
Now hiring (61)
Obesity (544)
Opinion (302)
Ovarian cancer (147)
Pain (171)
Pancreatic cancer (190)
Parkinson's disease (254)
Partnered (31)
Patents (443)
Patient recruitment (375)
Peanut (56)
People (62439)
Pharmaceutical (71)
Pharmacy benefit managers (30)
Phase I (22098)
Phase II (31227)
Phase III (23534)
Pipeline (3564)
Policy (296)
Postmarket research (2848)
Preclinical (9574)
Press Release (67)
Prostate cancer (223)
Psychedelics (45)
Radiopharmaceuticals (275)
Rare diseases (717)
Real estate (6432)
Recruiting (76)
Regulatory (25365)
Reports (53)
Research institute (2567)
Resumes & cover letters (488)
Rett syndrome (21)
RNA editing (14)
RSV (77)
Schizophrenia (137)
Series A (220)
Series B (170)
Service/supplier (13)
Sickle cell disease (88)
Special edition (25)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3860)
State (2)
Stomach cancer (19)
Supply chain (104)
Tariffs (87)
The Weekly (92)
Vaccines (1005)
Venture capital (75)
Weight loss (367)
Women's health (71)
Worklife (21)
Date
Today (131)
Last 7 days (519)
Last 30 days (3088)
Last 365 days (31753)
2025 (30016)
2024 (36590)
2023 (41486)
2022 (52743)
2021 (57530)
2020 (56433)
2019 (49683)
2018 (37676)
2017 (34258)
2016 (34300)
2015 (40228)
2014 (34329)
2013 (29772)
2012 (31758)
2011 (32094)
2010 (30606)
Location
Africa (966)
Alabama (79)
Alaska (7)
Arizona (298)
Arkansas (14)
Asia (42943)
Australia (7132)
California (10384)
Canada (3071)
China (965)
Colorado (438)
Connecticut (463)
Delaware (304)
Europe (95824)
Florida (1548)
Georgia (333)
Hawaii (2)
Idaho (65)
Illinois (825)
India (56)
Indiana (491)
Iowa (21)
Japan (356)
Kansas (125)
Kentucky (40)
Louisiana (25)
Maine (72)
Maryland (1342)
Massachusetts (7592)
Michigan (312)
Minnesota (586)
Mississippi (6)
Missouri (129)
Montana (31)
Nebraska (27)
Nevada (113)
New Hampshire (79)
New Jersey (2847)
New Mexico (31)
New York (2791)
North Carolina (1441)
North Dakota (9)
Northern California (4912)
Ohio (310)
Oklahoma (22)
Oregon (40)
Pennsylvania (2126)
Puerto Rico (19)
Rhode Island (45)
South America (1348)
South Carolina (59)
South Dakota (1)
Southern California (4027)
Tennessee (163)
Texas (1608)
United States (37568)
Utah (312)
Vermont (1)
Virginia (253)
Washington D.C. (81)
Washington State (844)
West Virginia (4)
Wisconsin (101)
Wyoming (2)
770,181 Results for "johnson and johnson vision care inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Halda Therapeutics Announces Acquisition by Johnson & Johnson
November 18, 2025
·
3 min read
Press Releases
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
November 18, 2025
·
6 min read
Press Releases
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
October 15, 2025
·
9 min read
Press Releases
Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook
October 15, 2025
·
19 min read
Press Releases
Johnson & Johnson to Participate in the Citi’s 2025 Global Healthcare Conference
November 5, 2025
·
1 min read
Press Releases
Johnson & Johnson receives European Commission approval of IMAAVY® (nipocalimab), a new FcRn blocker offering sustained disease control in a broad population of people living with generalised myasthenia gravis (gMG)
December 2, 2025
·
19 min read
Press Releases
Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
October 10, 2025
·
37 min read
Press Releases
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025
October 15, 2025
·
1 min read
Press Releases
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
October 22, 2025
·
1 min read
Press Releases
Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting
October 30, 2025
·
20 min read
1 of 77,019
Next
